Background-Hirschsprung disease (HSCR),
The RET proto-oncogene, on 10q11.2, is a major susceptibility gene for Hirschsprung disease (HSCR, MIM 142623), a common disorder occurring in 1 in 5000 live births and characterised by the absence of the intramural ganglia of Meissner and Auerbach in the hindgut, which results in functional intestinal obstruction. [1] [2] [3] [4] HSCR most commonly presents as isolated cases although it can be familial and may be inherited as an autosomal dominant or autosomal recessive trait, with reduced penetrance and male predominance. 1 5 Currently, at least seven related genes are believed to play some aetiological role in the pathogenesis of hereditary syndromic and non-syndromic HSCR.
The RET proto-oncogene encodes a receptor tyrosine kinase expressed in derivatives of the neural crest and neurectoderm. 6 7 Gain of function germline mutations in the RET protooncogene are associated with multiple endocrine neoplasia type 2 (MEN 2), an autosomal dominantly inherited cancer syndrome characterised by medullary thyroid carcinoma, phaeochromocytoma, and hyperparathyroidism. 8 9 Interestingly, loss of function germline RET mutations have been found in HSCR. 3 4 Depending on the series, up to 50% of familial HSCR cases and anywhere between 10 and 35% of sporadic cases were reported to be accounted for by loss of function germline RET mutations. [10] [11] [12] However, these series were highly selected, usually for familial cases or severe presentations. The only population based series, however, estimates the frequency of germline RET mutation in 69 unselected HSCR cases to be 7% and only 3% of isolated HSCR cases in this population based cohort had germline RET mutations. 13 Although several other putative HSCR susceptibility genes have been proposed, including those that encode glial cell line derived neurotrophic growth factor (GDNF), one of the ligands for RET, [14] [15] [16] endothelin-3 17 18 and endothelin receptor-beta (EDNRB), [19] [20] [21] [22] [23] [24] only germline heterozygous mutations in EDNRB occur in a significant minority of non-syndromic HSCR. 22 When HSCR and MEN 2 occur together, the great majority are found to have C620R and C618R mutations. 8 25 A single case family segregating both HSCR and MEN 2 was found to harbour a germline RET C620S mutation, and at the time of original ascertainment, the only subject to have both HSCR and MEN 2 carried a C620S RET mutation and the homozygous sequence polymorphism in exon 2, A45A (c.135G→A). 26 Extending this observation in a population based series of isolated HSCR cases from western Andalucia, Spain, we found that the A45A (c.135G→A) sequence variant and L769L (c.2307T→G) (exon 13) were significantly over-represented (p<0.0006) when compared to region matched, race matched normal controls. 27 In contrast, two other polymorphisms, G691S (c.2071C→A, exon 11) and S904S (c.2712C→G, exon 15), were underrepresented in the HSCR patients compared to controls (p=0.02). 27 Interestingly, similar findings were independently obtained in a series of HSCR cases from diVerent population bases, Germany 28 and the UK. 29 Using the same 64 isolated HSCR patients from our previous population based study 27 and newly accrued normal parents of these cases, we therefore sought to determine whether distinct germline RET sequence variant haplotypes could be directly associated with predisposition to HSCR.
Materials and methods

ISOLATED HSCR CASES
The western Andalucia region of Spain is serviced by the University Hospital "Virgen del Rocio" in Seville and is the major referral centre for HSCR, and so all HSCR cases seen at this institution may be considered representative of the population. This study used the first 64 consecutive cases of clinically sporadic HSCR seen at this institution in the first 13.5 months of study, described in detail previously. 27 
CLINICALLY UNAFFECTED PARENTS OF HSCR CASES AND NORMAL CONTROLS
Near the end of the study period, the unaVected parents of the isolated HSCR cases were recontacted to participate in the research protocol (in accordance with local institutional human protection committee rules). Forty nine parental couples and eight single parents agreed to participate.
Normal controls were unselected, unrelated, race matched subjects from Andalucia without a diagnosis of HSCR and who did not attend the medical genetic, paediatric surgical, or gastroenterological clinics.
MUTATION ANALYSIS
Genomic DNA was extracted from peripheral blood leucocytes from HSCR cases, their clinically unaVected parents or relatives, and normal controls using standard techniques. 30 To examine variant status at each of the polymorphic loci within RET, the appropriate RET amplicon for each of exons 2, 3, 7, 11, 13, 14, and 15 was generated as previously described. 25 27 The presence or absence of each polymorphism within each amplicon was assessed by diVerential restriction digestion with the appropriate enzymes as described, 27 31 32 according to the manufacturers' recommendations (Roche Life Technologies and Pharmacia Biotech). The products of restriction digestion were fractionated by electrophoresis through 2% agarose or 6% polyacrylamide gels and visualised under UV transillumination after ethidium bromide staining. When the primers were 5' labelled with fluorescent dyes, then the restricted amplicons were subjected to electrophoresis through an Alf-Express Automated DNA Sequencer (Pharmacia Biotech).
STATISTICAL ANALYSIS
Allelic frequencies at all seven RET polymorphic loci were determined and haplotypes formed (table 1). The frequencies of each haplotype were compared between the cases and race matched, region matched, normal controls who were unrelated to the HSCR subjects. Comparisons were performed using 2 contingency table tests with Yates's correction or (when computationally feasible) Fisher's exact test for tables with small expected cell counts. The criterion for statistical significance was set at =0.05. Odds ratios with Cornfield 95% confidence intervals were also generated at each haplotype. The asymptotic p values from the transmission disequilibrium tests were supported in each case by exact p values computed via direct evaluation or 10 000 simulations.
Where available, parental haplotypes were examined in the context of the aVected children's haplotypes. Transmitted and nontransmitted haplotypes were noted and compared. Statistical analyses and simulations were performed using S-Plus 4.5 (Mathsoft Inc).
Stepwise logistic regression was performed using SAS v6.09 (SAS Institute), with entry and retention significance level criteria of 0.05. Although the transmitted haplotypes are matched with non-transmitted haplotypes, 
Results
RET HAPLOTYPE ANALYSIS IN HSCR AND UNRELATED CONTROLS
Haplotypes, comprised of variants across seven polymorphic loci in the coding region of RET, could be generated for 62 of the 64 HSCR cases and for 65 of the 104 race matched, region matched controls. Phase was successfully determined for 62 of 64 HSCR cases, 54 parents, and 65 controls. Among the 62 HSCR cases, seven with both parents lost to follow up had their haplotypes inferred from the haplotype compositions of the other subjects. This inference has no eVect on the transmission disequilibrium test results, which use only families with informative parents. There were 12 unique haplotypes, labelled A-L, among cases and controls combined (tables 1 and 2A). Since recombination events among loci will be extremely rare, the haplotypes are viewed as individual alleles of a single locus. Apart from the haplotype comprised of the wild type allele at each of the polymorphic loci (haplotype A), there were 11 haplotypes (B-L) made up of various combinations and permutations of sequence variant and wild type sequence at each locus (table 1) . The three most common haplotypes represented among controls occurring in more than 15% of chromosomes were A (36.2%), D (A432A only, rest wild type; 20%), and G [G691S (c.2071C→A) and S904S (c.2712C→G; 17.7%)] (table 2A, fig 1) . In contrast, the most common haplotypes occurring in 15% or more of HSCR chromosomes were haplotypes B (A45A (c.135G→A) only; 33% of chromosomes) and C (A45A Because the non-transmitted parental haplotypes are available, we have also used these for analyses of association with disease that are highly robust to population stratification. 34 35 Table 2B shows the distribution of haplotypes that are transmitted to HSCR probands, those that are not transmitted from the parents, and those from the control group. The nontransmitted v control haplotypes do not appear to diVer greatly in distribution, although a comparison of these two groups is significant at the 0.05 level ( The transmission disequlibrium test 37 tests for association in a manner that acknowledges the matching of observed alleles, or in this instance haplotypes, in the parents of aVected subjects. Only heterozygous parents are informative when performing this test. Although originally designed for biallelic markers, we applied multiple allelic/haplotype extensions here.
Figure 1 Frequency of RET genotypes in HSCR cases (white bars) versus normal controls (striped bars
35 Table 3 presents the results comparing each haplotype to the group of remaining haplotypes. The highest frequencies of nontransmission were observed with haplotypes A, D, and G, and this was more pronounced when compared to the frequency of these haplotypes among the aVected oVspring. In contrast, haplotypes B, C, F, and H had the lowest rates of parental non-transmission, that is, these haplotypes were the most frequently transmitted from parent to aVected oVspring. As an overall test of association, Spielman and Ewens 35 propose a summation of the individual contributions. The corresponding statistic is 2 11 =56.7, p<<0.0001. Another overall test uses the Bonferroni corrected p value to the maximum 2 1 statistic of the individual haplotypes, which yields p=0.002. Simulation based methods conditioned on the parental genotypes produced p values of 0.0001 and 0.0004, respectively.
ASSOCIATION OF INDIVIDUAL POLYMORPHIC LOCI WITH DISEASE
A series of transmission disequilibrium tests were also performed for each of the seven polymorphic loci (table 4) . In these comparisons, only A45A (c.135G→A) and V125V were significant at the 0.05 level. However, G691S (c.2071C→A), L769L (c.2307T→G), and S904S (c.2712C→G) were suggestive with exact p<0.10. In order to analyse more fully the eVect of each locus on the transmission of a haplotype 
HAPLOTYPE PAIRS (GENOTYPE) IN HSCR CASES AND CONTROLS
Genotypes comprising pairs of RET haplotypes were generated for cases, their participating parents, and controls. The three most common genotypes among the 65 controls include AD (12 or 18.5%), AG (seven or 10.8%), and AA (eight or 12.3%) (fig 1) . Interestingly, only three (4.8%) HSCR cases carried one of these three genotypes and all three were AD. The three most common HSCR genotypes were BB (seven or 11.3%), BC (six or 9.7%), and BH (six or 9.7%). Only two (3.1%) normal controls carried any of these three genotypes and both were BC. In summary, there were 38 diVerent genotypes among cases and controls combined. Inspection of the genotypes in these two groups showed that the genotype distribution between cases and controls was distinct ( 37 2 =93.8, p<<0.0001). For example, BB, BC, BD, and CD are prominently represented among HSCR cases, together accounting for >35% of the case genotypes, yet these four genotypes are not represented among the region matched, race matched normal controls. Conversely, AA, AG, DD, GG, and GJ are commonly represented in the controls, together accounting for 43% of the control genotypes, and yet they are never seen among the HSCR cases.
Discussion
Among the western Andalucian HSCR cases, all RET haplotypes harbouring A45A (c.135G→A) appeared to be over-represented among HSCR cases compared to region matched, race matched, normal controls, thus confirming previous single site analyses and our hypotheses. 27 Interestingly, the L769L (c.2307T→G) polymorphism, which was previously found to be over-represented in single locus analysis in HSCR, 27 was very rare by itself. It almost always occurred with the A45A (c.135G→A) variant, suggesting perhaps that it could be in linkage disequilibrium with the A45A (c.135G→A) allele. Conversely, selected non-A45A (c.135G→A) bearing haplotypes such as A and G were over-represented among controls. Even more powerfully associated with HSCR are the genotypes comprising specific RET haplotype pairs, such that our data might suggest an autosomal recessive or dose dependent (additive) low penetrance mechanism for a large proportion of isolated HSCR. The precise haplotype-HSCR and single locus-HSCR associations compared to unrelated controls diVer slightly from those compared to the unaVected parents. In our earlier report, 27 G691S (c.2071C→A)/S904S (c.2712C→G) were reported as conferring an apparent protective eVect. Although the current results parallel an earlier report using unrelated control samples, the requirements of the transmission disequilibrium test reduce the eVective sample size, so that the eVect of G691S (c.2071C→A)/S904S (c.2712C→G) is not statistically significant here at the 0.05 level. Similarly, the stepwise multiple logistic regression shows that the eVect of G691S (c.2071C→A)/S904S (c.2712C→G) is no longer suggestive in models which include A45A (c.135G→A). It can be seen by inspection of the haplotypes that variant A45A (c.135G→A) is associated with wild type sequence at codons 691 and 904 such that only one transmitted haplotype comprised variants A45A (c.135G→A) and G691S (c.2071C→A)/S904S (c.2712C→G). Thus, the apparent "HSCR protective" eVect of variant G691S (c.2071C→A)/S904S (c.2712C→G) is largely confounded with the (stronger) eVect at codon 45. Because of the association of the two loci, it is diYcult to explore their precise joint eVect on transmission status further. The observations using the transmission disequilibrium test have the advantage of being highly robust to population stratification, and there is evidence (table 2A, B) that the control haplotype distribution diVers from that of the non-transmitted haplotypes.
Although this exploratory data set is relatively small, there are strong indications that haplotype pairs interact with each other to modulate HSCR phenotype. Under a simple additive (that is, dose dependent) or autosomal recessive model, therefore, we would expect that the presence of two HSCR associated haplotypes would be overwhelmingly associated with HSCR only and not controls. Conversely, the presence of two control associated haplotypes in a single subject should be strongly associated with normal controls and not with HSCR. In accordance with this model, the BB genotype was observed in seven (11.3%) HSCR cases but no controls. The AA, DD, and GG genotypes combined have been found in a total of 18 (27.7%) controls but no HSCR cases. Extrapolation of these observations would then lead to the hypothesis that heterozygous combinations of HSCR associated haplotypes would also be mainly associated with HSCR; similarly, heterozygous com- Although the F haplotype is relatively uncommon, it would appear that the F haplotype is particularly associated with HSCR and is relatively predominant. All genotypes with at least one F chromosome are only observed in HSCR cases no matter what the opposite chromosome is. The AF genotype, comprising the control associated A haplotype and the HSCR associated F haplotype, has been seen only in two HSCR cases and no controls, with the caveat of small numbers. The AB genotype was observed among six (9.2%) controls and two (3.2%) HSCR cases, perhaps suggesting a shared eVect although another explanation is also possible (see below).
Genotypes with at least one E haplotype are worthy of note. The E haplotype contains the S836S variant which has been found to be associated with cases diagnosed with sporadic medullary thyroid carcinoma, in particular those whose tumours harbour somatic RET M918T. 32 If this observation is extrapolated, then the E haplotype may be viewed as a low penetrance "gain of function" RET allele, and should not be associated with HSCR and perhaps could "protect" against HSCR. The E haplotype is relatively rare in various populations at large 28 31 32 as well as in HSCR and so single site analysis at codon 836 and haplotype analysis (above) among the western Andalucian HSCR were not able to show that S836S is significantly under-represented in this population compared to controls because of small numbers. However, inspection indicates that there are clearly fewer S836S alleles among HSCR compared to controls both in the western Andalucian data set 27 and that from a German population. 28 Most genotype combinations with haplotype E, for example, AE, DE, GE, and EJ, occur among normal controls.
There are genotypes in the western Andalucian cohort of cases and controls which do not appear to "fit" our hypotheses. One of the most obvious examples would be the AD genotype. The A haplotype is significantly overrepresented among controls compared to HSCR and the D haplotype is probably over-represented among controls as well. Thus, the prediction under a simple, additive model would be that the AD genotype is observed only in controls. Although 12 (18.5%) controls carry the AD genotype, three (5%) isolated HSCR cases also have the AD genotype. It is possible that HSCR cases found to have non-HSCR associated genotypes harbour (that is, require) germline high penetrance mutations which result in HSCR. Similarly, it might be predicted under our simple additive model that the BC genotype would only be observed among HSCR cases but not controls. However, while six (9.7%) HSCR cases have this genotype, two (3%) controls also have this genotype. Currently, there is no obvious universal explanation except that other loci are also involved, a postulate that has already been established 38 and recently expanded, at least for familial HSCR. 39 However, it is also possible that the "controls" do have HSCR with decreased expression, perhaps manifesting as constipation and hence these subjects have not sought medical attention.
In summary, our observations show that RET genotypes comprising specific haplotypes of RET coding sequence variants are associated with isolated HSCR while other distinct haplotype pairs are associated with control status. Our data suggest that genotypes with haplotypes comprising one specific variant, A45A (c.135G→A), are particularly associated with HSCR. Whether it is the RET haplotype per se or whether particular haplotype(s) are in linkage disequilibrium with another low penetrance, autosomal recessive, HSCR susceptibility gene is as yet unknown.
A larger case-control series in this population as well as similar studies in other populations are required to confirm our findings. Systematic functional analyses will also need to be performed to help elucidate the precise mechanism of haplotype associated susceptibility.
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